Structures by: Dutkiewicz G.
Total: 64
C15H15NOS
C15H15NOS
Crystals (2012) 2, 3 1058-1066
a=9.2080(4)Å b=14.0485(7)Å c=10.3826(6)Å
α=90.00° β=90.00° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.3738(7)Å b=10.8501(7)Å c=11.8301(9)Å
α=90.00° β=98.615(7)° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.6092(8)Å b=10.8355(8)Å c=11.1346(9)Å
α=90.00° β=98.643(6)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.6941(6)Å b=10.7909(4)Å c=8.6586(3)Å
α=90.00° β=102.184(4)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.5187(8)Å b=10.9358(5)Å c=8.8141(4)Å
α=90.00° β=101.245(5)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.1766(19)Å b=11.2809(14)Å c=8.9334(14)Å
α=90.00° β=98.726(13)° γ=90.00°
C8H11N3O5S
C8H11N3O5S
New Journal of Chemistry (2001)
a=7.701(2)Å b=30.779(6)Å c=9.425(2)Å
α=90.00° β=92.98(3)° γ=90.00°
C8H11N3O5S
C8H11N3O5S
New Journal of Chemistry (2001)
a=10.626(2)Å b=15.597(3)Å c=7.1820(10)Å
α=90.00° β=103.38(2)° γ=90.00°
N-n-butyltetrachlorophthalimide
C12H9Cl4NO2
CrystEngComm (2019)
a=5.19987(6)Å b=11.27107(12)Å c=12.08308(11)Å
α=103.6423(8)° β=98.8523(9)° γ=101.4977(9)°
2-[(2<i>E</i>)-2-(1<i>H</i>-Imidazol-4-ylmethylidene)-1-methylhydrazinyl]pyridine
C10H11N5
Acta Crystallographica Section C (2020) 76, 4 367-374
a=10.1953(4)Å b=14.2866(5)Å c=14.9027(5)Å
α=90° β=103.845(3)° γ=90°
2-[(2<i>E</i>)-2-(1<i>H</i>-Imidazol-2-ylmethylidene)-1-methylhydrazinyl]-1<i>H</i>-benzimidazole monohydrate
C12H12N6,H2O
Acta Crystallographica Section C (2020) 76, 4 367-374
a=8.2711(7)Å b=14.0773(12)Å c=22.2655(16)Å
α=90° β=99.373(8)° γ=90°
5-{(1<i>E</i>)-[2-(1<i>H</i>-1,3-Benzodiazol-2-yl)-2-methylhydrazinylidene]methyl}-1<i>H</i>-imidazol-3-ium trifluoromethanesulfonate monohydrate
C12H13N6,CF3O3S,H2O
Acta Crystallographica Section C (2020) 76, 4 367-374
a=8.9818(5)Å b=9.5704(5)Å c=21.1278(12)Å
α=90° β=95.383(5)° γ=90°
2-{(2<i>E</i>)-1-Methyl-2-[(1<i>H</i>-imidazol-3-ium-2-yl)methylidene]hydrazinyl}pyridinium bis(trifluoromethanesulfonate)
C10H13N52,2(CF3O3S)
Acta Crystallographica Section C (2020) 76, 4 367-374
a=12.2524(5)Å b=14.0242(5)Å c=11.4488(5)Å
α=90° β=102.259(4)° γ=90°
2-{(2<i>E</i>)-1-Methyl-2-[(1-methyl-1<i>H</i>-imidazol-2-yl)methylidene]hydrazinyl}-1<i>H</i>-benzimidazole hydrate
4(C13H14N6),5(H2O)
Acta Crystallographica Section C (2020) 76, 4 367-374
a=9.1836(3)Å b=16.5814(4)Å c=20.8041(6)Å
α=106.760(2)° β=97.854(2)° γ=103.408(2)°
Pyrazine--phthalic acid (1/1)
C4H4N2,C8H6O4
Acta Crystallographica Section C (2018) 74, 11 1420-1426
a=6.6714(5)Å b=7.3296(8)Å c=12.9870(9)Å
α=90.425(7)° β=96.907(6)° γ=114.347(9)°
Pyrazine--hemimellitic acid--water (1/2/2)
C4H4N2,2(C9H6O6),2(H2O)
Acta Crystallographica Section C (2018) 74, 11 1420-1426
a=6.6537(8)Å b=8.3316(11)Å c=11.5433(15)Å
α=73.100(12)° β=75.565(11)° γ=73.001(11)°
Pyrazine--hemimellitic acid (1/1)
C4H4N2,C9H6O6
Acta Crystallographica Section C (2018) 74, 11 1420-1426
a=7.7184(9)Å b=9.9393(10)Å c=10.0300(10)Å
α=115.029(10)° β=112.471(10)° γ=92.672(9)°
Pyrazine--pyromellitic acid (3/1)
3(C4H4N2),C10H6O8
Acta Crystallographica Section C (2018) 74, 11 1420-1426
a=7.0481(7)Å b=22.365(2)Å c=7.2120(7)Å
α=90° β=96.967(9)° γ=90°
1,2-Dimethyl-4-nitro-5-morpholine-imidazole
C9H14N4O3
Acta Crystallographica Section B (2003) 59, 4 487-491
a=8.589(2)Å b=6.6750(10)Å c=10.657(2)Å
α=90.00° β=112.23(3)° γ=90.00°
1,2-Dimethyl-4-nitro-5-morpholine-imidazole hydrate
C9H14N4O3,H2O
Acta Crystallographica Section B (2003) 59, 4 487-491
a=10.1972(11)Å b=10.2908(9)Å c=11.1812(12)Å
α=95.319(8)° β=92.235(9)° γ=90.777(8)°
1,2-Dimethyl-4-nitro-5-morpholine-imidazole hydrate
C9H14N4O3,H2O
Acta Crystallographica Section B (2003) 59, 4 487-491
a=10.1087(7)Å b=10.2497(8)Å c=10.9623(8)Å
α=95.888(6)° β=92.119(6)° γ=90.188(6)°
2-methyl-1,3-cyclopentanedione
C6H8O2
Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials (2014) 70, 2 197-211
a=12.402(3)Å b=6.470(2)Å c=6.321(2)Å
α=90.00° β=93.69(2)° γ=90.00°
11,12-seco-12,13-didehydromultiflorine perchlorate hydrate
C15H23N2O11,Cl1O41,H2O
Acta Crystallographica Section C (1995) 51, 6 1182-1184
a=8.014(2)Å b=8.633(2)Å c=12.600(3)Å
α=90.00° β=90.53(3)° γ=90.00°
7,7-Dibromo-3-dibromomethylene-2,2-dimethyl-1-hydroxy-8,9,10,trinorbornane
C10H12Br4O
Acta Crystallographica Section C (1995) 51, 4 736-738
a=8.8937(6)Å b=7.7404(6)Å c=9.5873(6)Å
α=90.00° β=91.528(9)° γ=90.00°
Tetraammonium benzene-1,2,4,5-tetracarboxylate dihydrate
4NH4,C10H2O84,2H2O
Acta Crystallographica Section E (2007) 63, 10 o4101
a=11.6054(10)Å b=6.7122(6)Å c=10.5718(8)Å
α=90.00° β=102.821(7)° γ=90.00°
(<i>Z</i>)-<i>N</i>-[2-(Dimethylammonio)ethyl]thioacetamide chloride
C6H15N2S,Cl
Acta Crystallographica Section E (2008) 64, 1 o229-o229
a=5.9935(2)Å b=7.7461(3)Å c=10.8253(4)Å
α=79.489(3)° β=79.796(3)° γ=87.863(3)°
(1-thyminyl)acetamide
C7H9N3O3
Acta Crystallographica Section C (2006) 62, 6 o344-o345
a=8.03880(10)Å b=6.14760(10)Å c=15.83900(10)Å
α=90.00° β=92.9230(10)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=34.176(3)Å b=9.1227(9)Å c=12.1235(11)Å
α=90.00° β=91.962(8)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=33.849(3)Å b=9.0250(10)Å c=11.9800(10)Å
α=90.00° β=92.510(10)° γ=90.00°
1-chloroacetyl-2,6-diphenyl-3-(propan-2-yl)piperidin-4-one oxime
C22H25ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=9.4690(10)Å b=16.658(2)Å c=12.653(2)Å
α=90.00° β=90.290(10)° γ=90.00°
1-(2-cyanoethyl)thymine
C8H9N3O2
Acta Crystallographica Section C (2007) 63, 3 o201-o203
a=11.2597(4)Å b=4.4118(2)Å c=17.6256(6)Å
α=90.00° β=98.253(3)° γ=90.00°
4,4'-(1,2,4,5-Tetrazine-3,6-diyl)dibenzonitrile
C16H8N6
Acta Crystallographica Section E (2009) 65, 4 o824
a=4.8447(5)Å b=12.1054(12)Å c=11.6927(11)Å
α=90.00° β=94.363(8)° γ=90.00°
(4-Bromophenyl)(1<i>H</i>-indol-7-yl)methanone
C15H10BrNO
Acta Crystallographica Section E (2009) 65, 11 o2933
a=11.3241(4)Å b=7.4651(3)Å c=14.9579(5)Å
α=90.00° β=103.100(4)° γ=90.00°
4-(4-Chlorophenyl)piperidin-4-ol
C11H14ClNO
Acta Crystallographica Section E (2010) 66, 3 o562
a=11.3706(10)Å b=9.5204(8)Å c=10.6164(9)Å
α=90.00° β=108.458(8)° γ=90.00°
Fluconazolium picrate
C13H13F2N6O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 10 o2568
a=5.6470(10)Å b=17.347(2)Å c=22.571(2)Å
α=90.00° β=94.270(10)° γ=90.00°
(<i>E</i>)-3-(4-Chlorophenyl)-1-(1-naphthyl)prop-2-en-1-one
C19H13ClO
Acta Crystallographica Section E (2009) 65, 12 o3255-o3256
a=12.0392(14)Å b=8.0544(5)Å c=7.8472(6)Å
α=90.00° β=98.091(10)° γ=90.00°
Chloranilic acid
C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 2 o497-o498
a=7.5338(12)Å b=5.5225(10)Å c=8.5720(12)Å
α=90.00° β=104.868(11)° γ=90.00°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4,6-bis(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H18F2O3
Acta Crystallographica Section E (2011) 67, 2 o336
a=11.062(2)Å b=11.675(3)Å c=13.854(3)Å
α=90.00° β=92.89(2)° γ=90.00°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4-(2,4-dichlorophenyl)-6-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H17Cl2FO3
Acta Crystallographica Section E (2011) 67, 2 o445-o446
a=32.321(5)Å b=5.437(2)Å c=22.309(3)Å
α=90.00° β=90.00° γ=90.00°
1-methylpiperazine-1,4-diium dipicrate
C5H14N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o390-o391
a=8.2001(12)Å b=10.1780(15)Å c=13.7399(18)Å
α=89.798(12)° β=78.130(11)° γ=81.558(12)°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4-(4-chlorophenyl)-6-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate toluene hemisolvate
C21H18ClFO3,0.5(C7H8)
Acta Crystallographica Section E (2011) 67, 2 o334-o335
a=7.572(2)Å b=11.259(3)Å c=13.362(3)Å
α=69.42(2)° β=86.58(2)° γ=70.98(2)°
3-Methyl-1,2,4-triazolo[3,4-<i>a</i>]phthalazine monohydrate
C10H8N4,H2O
Acta Crystallographica Section E (2009) 65, 11 o2694
a=7.3009(9)Å b=7.9253(9)Å c=9.2755(10)Å
α=109.663(10)° β=104.910(10)° γ=95.830(9)°
(<i>E</i>)-3-(Biphenyl-4-yl)-1-(3-bromophenyl)prop-2-en-1-one
C21H15BrO
Acta Crystallographica Section E (2009) 65, 11 o2856-o2857
a=6.0920(10)Å b=7.2950(10)Å c=36.619(2)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Chlorophenoxy)acetohydrazide
C8H9ClN2O2
Acta Crystallographica Section E (2009) 65, 12 o3189
a=6.4440(10)Å b=4.0110(10)Å c=35.369(4)Å
α=90.00° β=91.890(10)° γ=90.00°
2-Isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
C16H26O5S
Acta Crystallographica Section E (2009) 65, 12 o3169
a=5.3290(10)Å b=13.8670(10)Å c=23.490(2)Å
α=90.00° β=90.00° γ=90.00°
Valyl benzyl ester chloride
C12H18NO2,Cl
Acta Crystallographica Section E (2010) 66, 2 o324
a=9.7050(10)Å b=5.4060(10)Å c=13.116(2)Å
α=90.00° β=96.580(10)° γ=90.00°
2-Chloro-<i>N</i>-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide
C15H10Cl3NO2
Acta Crystallographica Section E (2010) 66, 2 o499
a=7.5776(9)Å b=10.1565(10)Å c=10.7862(12)Å
α=70.069(8)° β=77.604(9)° γ=70.388(8)°
(<i>E</i>)-1-(4-Methylphenyl)ethanone [8-(trifluoromethyl)quinolin-4-yl]hydrazone
C19H16F3N3
Acta Crystallographica Section E (2010) 66, 4 o874
a=8.2811(9)Å b=14.8443(15)Å c=13.5325(15)Å
α=90.00° β=90.601(9)° γ=90.00°
3-(3-Bromo-4-methoxyphenyl)-1,5-diphenylpentane-1,5-dione
C24H21BrO3
Acta Crystallographica Section E (2010) 66, 4 o816
a=12.7305(4)Å b=7.14024(19)Å c=22.8133(8)Å
α=90.00° β=105.602(3)° γ=90.00°
2-(4-Methoxyphenyl)-6-trifluoromethyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]quinoline monohydrate
C19H13F3N2O,H2O
Acta Crystallographica Section E (2010) 66, 5 o1111-o1112
a=13.8380(10)Å b=7.0432(5)Å c=17.758(2)Å
α=90.00° β=102.743(8)° γ=90.00°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-[4-(dimethylamino)phenyl]prop-2-en-1-one
C15H13Cl2NOS
Acta Crystallographica Section E (2010) 66, 5 o1139
a=7.2637(9)Å b=8.1136(9)Å c=13.478(2)Å
α=89.011(9)° β=79.710(10)° γ=73.070(10)°
(2<i>E</i>)-1-(4-Bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
C15H10BrFO
Acta Crystallographica Section E (2010) 66, 5 o1243-o1244
a=4.0060(5)Å b=23.1253(12)Å c=13.4933(9)Å
α=90.00° β=96.344(6)° γ=90.00°
{2,2'-[1,1'-(Ethane-1,2- diyldinitrilo)diethylidyne]diphenolato}bis(pyrrolidine)cobalt(III) perchlorate <i>p</i>-xylene hemisolvate
C26H36CoN4O2,ClO4,0.5(C8H10)
Acta Crystallographica Section E (2010) 66, 12 m1590-m1591
a=13.118(2)Å b=16.551(3)Å c=13.784(2)Å
α=90.00° β=92.87(2)° γ=90.00°
2-methylimidazolium picrate
C4H7N2,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o235
a=7.0983(9)Å b=21.644(2)Å c=8.1583(9)Å
α=90.00° β=100.327(12)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
C17H15BrO2
Acta Crystallographica Section E (2011) 67, 4 o1024
a=11.680(2)Å b=11.654(2)Å c=10.834(2)Å
α=90.00° β=93.07(2)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4-fluorophenyl)prop-2-en-1-one
C16H12BrFO2
Acta Crystallographica Section E (2011) 67, 5 o1090
a=11.056(2)Å b=4.1110(15)Å c=30.825(5)Å
α=90.00° β=96.76(2)° γ=90.00°
Bis[μ-4-(2-oxidobenzylidene)thiosemicarbazidato- κ^4^<i>S</i>,<i>N</i>^1^,<i>O</i>:<i>O</i>]bis[(pyridine-κ<i>N</i>)zinc]
C26H24N8O2S2Zn2
Acta Crystallographica Section E (2012) 68, 2 m106-m107
a=10.2641(3)Å b=17.3160(6)Å c=16.6473(5)Å
α=90.00° β=104.706(3)° γ=90.00°
Ethyl <i>N</i>-(2-benzoyl-4-chlorophenyl)ethanecarboximidate
C17H16ClNO2
Acta Crystallographica Section E (2012) 68, 3 o916
a=7.9674(11)Å b=8.6993(17)Å c=11.596(2)Å
α=104.499(17)° β=94.871(14)° γ=95.001(14)°
Tramadolium picrate
C16H26NO2,C6H2N3O7
Acta Crystallographica Section E (2012) 68, 3 o600
a=8.5674(10)Å b=12.3664(12)Å c=13.2276(13)Å
α=113.003(9)° β=107.686(10)° γ=95.541(9)°
4-[(4-Benzyloxybenzylidene)amino]-1,5-dimethyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C25H23N3O2
Acta Crystallographica Section E (2012) 68, 5 o1324
a=19.8137(19)Å b=6.1588(4)Å c=18.0784(14)Å
α=90.00° β=108.881(9)° γ=90.00°
[<i>S</i>-Allyl-4-(4-hydroxy-2-oxidobenzylidene-κ<i>O</i>)-1-(2- oxidobenzylidene-κ<i>O</i>)isothiosemicarbazidato- κ^2^<i>N</i>^1^,<i>N</i>^4^](ethanol-κ<i>O</i>)dioxidouranium(VI) ethanol monosolvate
C20H21N3O6SU,C2H6O
Acta Crystallographica Section E (2011) 67, 12 m1824-m1825
a=12.0152(4)Å b=17.6609(4)Å c=13.1076(3)Å
α=90.00° β=109.195(3)° γ=90.00°
(<i>R</i>)-Doxylaminium (<i>R</i>,<i>R</i>)-tartrate
C17H23N2O,C4H5O6
Acta Crystallographica Section E (2012) 68, 4 o1054-o1055
a=7.4419(4)Å b=18.4394(8)Å c=8.3517(4)Å
α=90.00° β=108.301(5)° γ=90.00°
1-[Bis(4-fluorophenyl)methyl]piperazine
C17H18F2N2
Acta Crystallographica Section E (2012) 68, 9 o2817
a=12.1574(5)Å b=8.8559(2)Å c=13.8604(4)Å
α=90.00° β=93.355(3)° γ=90.00°
1-(3-cyanopropyl)thymine
C9H11N3O2
Acta Crystallographica Section C (2007) 63, 3 o201-o203
a=4.8591(8)Å b=9.8205(12)Å c=10.5979(11)Å
α=75.815(10)° β=78.364(12)° γ=80.780(11)°